Miljković Nenad, Godman Brian, van Overbeeke Eline, Kovačević Milena, Tsiakitzis Karyofyllis, Apatsidou Athina, Nikopoulou Anna, Yubero Cristina Garcia, Portillo Horcajada Laura, Stemer Gunar, Kuruc-Poje Darija, De Rijdt Thomas, Bochenek Tomasz, Huys Isabelle, Miljković Branislava
Institute for Orthopaedic Surgery "Banjica", University of Belgrade, Belgrade, Serbia.
Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Front Med (Lausanne). 2020 May 12;7:157. doi: 10.3389/fmed.2020.00157. eCollection 2020.
Medicine shortages result in great risk for the continuity of patient care especially for antimicrobial treatment, potentially enhancing resistance rates and having a higher economic impact. This study aims to identify, describe, assess, and assign risk priority levels to potential failures following substitution of antimicrobial treatment due to shortages among European hospitals. Furthermore, the study investigated the impact of corrective actions on risk reduction so as to provide guidance and improve future patient care. Health-care failure mode and effect analysis (HFMEA) was applied to hospitals in Austria (H-AT), Belgium (H-BE), Croatia (H-CR), Greece (H-GR), Spain (H-SP), and Serbia (H-SR). Multidisciplinary teams identified processes, failure modes, causes, and corrective actions related to antibiotic substitution following medicine shortages. Characteristics of study hospitals as well as severity, probability, and hazard scores (HSs) of failure modes/causes were analyzed using Microsoft Office Excel 2010 and IBM SPSS Statistics® via descriptive and inferential statistics. Through HFMEA, 74 failure modes were identified, with 53 of these scoring 8 or above on the basis of assigned severity and probability for a failure. Severity of failure modes differed before and after corrective actions in H-CR, H-GR, and H-SR ( < 0.005). Their probability differed in all study hospitals ( < 0.005) when compared before and after corrective actions aimed to be implemented. The highest number of failure-mode causes was detected in H-CR (46) and the lowest in H-SP (16). Corrective actions can address failure modes and lower HSs; therein, all teams proposed the following: structuring communication among stakeholders, introducing electronic prescribing, strengthening pharmacists' involvement, and increasing effectiveness of the ward stock assessment. These proposed actions led to HS reductions up to 83%. There is a lack of structure in addressing risks associated with antibiotic substitution following shortages. Furthermore, lack of communication, data scarcity on availability of antibiotics, non-supportive information technology (IT) systems, and lack of internal substitution protocols hinder quick assessment of alternatives addressing patient needs. Nevertheless, the study shows that health-care professionals manage to secure optimal antimicrobial treatment for patients using available IT and human resources.
药品短缺给患者护理的连续性带来了巨大风险,尤其是在抗菌治疗方面,这可能会提高耐药率并产生更高的经济影响。本研究旨在识别、描述、评估欧洲医院因药品短缺而进行抗菌治疗替代后的潜在失败情况,并为其确定风险优先级。此外,该研究还调查了纠正措施对降低风险的影响,以便提供指导并改善未来的患者护理。医疗失效模式与效应分析(HFMEA)应用于奥地利(H-AT)、比利时(H-BE)、克罗地亚(H-CR)、希腊(H-GR)、西班牙(H-SP)和塞尔维亚(H-SR)的医院。多学科团队确定了与药品短缺后抗生素替代相关的流程、失效模式、原因和纠正措施。使用Microsoft Office Excel 2010和IBM SPSS Statistics® 通过描述性和推断性统计分析了研究医院的特征以及失效模式/原因的严重程度、发生概率和危害评分(HS)。 通过HFMEA,共识别出74种失效模式,其中53种基于指定的严重程度和失效概率得分在8分及以上。在H-CR、H-GR和H-SR中,纠正措施前后失效模式的严重程度有所不同(<0.005)。与旨在实施的纠正措施前后相比,所有研究医院中其发生概率均有所不同(<0.005)。在H-CR中检测到的失效模式原因数量最多(46个),在H-SP中最少(16个)。纠正措施可以解决失效模式并降低HS;其中,所有团队都提出了以下建议:构建利益相关者之间的沟通、引入电子处方、加强药剂师的参与以及提高病房库存评估的有效性。这些建议措施使HS降低了83%。 在应对短缺后抗生素替代相关风险方面缺乏系统性。此外,沟通不畅、抗生素可获得性数据匮乏、信息技术(IT)系统不支持以及缺乏内部替代方案阻碍了对满足患者需求的替代方案的快速评估。尽管如此,该研究表明,医疗保健专业人员能够利用现有的IT和人力资源为患者确保最佳的抗菌治疗。